Now, University of Pennsylvania researchers have revealed how a reduction in mitochondrial DNA content
leads human breast cancer cells to take on aggressive, metastatic properties.
Not exact matches
The three Ras genes found in
humans — H - Ras, K - Ras and N - Ras — were among the first to be linked to
cancer development, and a new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected pr
cancer development, and a new study
led by VCU Massey
Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected pr
Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved
breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected pr
cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected process.
Lead author Moustafa Abdalla writes: «Almost all genomic studies of
breast cancer have focused on well - established tumours because it is technically challenging to study the earliest mutational events occurring in
human breast epithelial cells.»
«One of the most common viruses in
humans may promote
breast cancer development: Findings could
lead to new prevention strategies.»
Therefore, his team,
led by postdoctoral fellow Gayatri Arun, set out to discover what would happen if mice that model
human metastatic
breast cancer were bred with the mice lacking Malat1.
Humans have an ortholog of the murine Nrk gene, and considering that the gene expression pattern in
breast tumor in Nrk mutant mice was similar to that in
human luminal B
breast cancer, the findings of this study may
lead to further understanding of the mechanisms of
human breast cancer suppression and to advances in its diagnosis and therapy.
Aug 8, 2008 Two New Predisposition Genes For
Breast, Thyroid And Kidney
Cancers Could
Lead to More Accurate Diagnosis and Earlier Detection of These
Cancers Charis Eng, MD, PhD, Sondra J and Stephen R Hardis Endowed Chair of
Cancer Genomic Medicine and Chair, GMI, and her team published in the Aug 8, 2008 issue of the American Journal of
Human Genetics that germline mutations in SDHB and SDHD, which play key roles in the mitochondria (the cell's power houses), predispose to Cowden and Cowden - like syndromes.
The study provides a new path forward in
human research as about half of the
breast cancers treated with this common
cancer therapy do not respond well, say researchers at the Georgetown Lombardi Comprehensive Cancer Center, who led the multi-institutional res
cancer therapy do not respond well, say researchers at the Georgetown Lombardi Comprehensive
Cancer Center, who led the multi-institutional res
Cancer Center, who
led the multi-institutional research.
Oxybenzone — This substance has been shown in studies to be a potent hormone disruptor, mimicking estrogen within the
human body and potentially
leading to diseases such as
breast cancer, endometriosis, decreased sperm count, and prostate and testicular
cancers.
A recent study out of Georgetown University showed that the metals mercury, copper, cobalt, nickel,
lead, tin, chromium and vanadate activated estrogen receptor alpha sites in
human breast cell
cancer lines in ways similarly to the
human estrogen estradiol.
She puts a
human face on statistics ranking
breast cancer as the second
leading cause of
cancer deaths in women in the United States.